blood test biomarker prostate cancer
Prostate Cancer Screening Is Bleeding Your Health Budget
Traditional prostate cancer screening can drain a retiree’s budget, but newer blood-test biomarkers offer a cost-effective alternative that catches disease earlier and reduces expensive follow-up procedures. 2024 data shows that 30% fewer biopsies are needed when clinicians add a gene-signature panel to the standard PSA test. Medical Disclaimer: This